Honest Counsel
Open, thoughtful guidance grounded in experience, professional judgment, and integrity.
About John
John Zaya is the Founder and Principal of Zaya Advisory, an independent strategic advisory practice focused on corporate strategy, strategic finance, financial planning and analysis (FP&A), corporate development, business development, and strategic partnerships.
Drawing upon experience across global financial institutions, multinational corporations, healthcare, life sciences, and emerging businesses, John brings financial discipline, international perspective, and a relationship-driven approach to helping organizations navigate complexity, pursue growth, and create long-term value.

Life Sciences
Deep industry experience across healthcare, biotechnology, pharmaceuticals, and medical technology.
Strategy + Finance
Connecting financial insight, strategic priorities, investment decisions, and execution.
Boston + Global Perspective
Boston roots. International experience. Global connections.
Relationships + Opportunity
Connecting people, ideas, and opportunities to advance meaningful progress.

Founder & Principal | Zaya Advisory
John Zaya’s professional career spans global institutional finance, international banking, executive financial management, multinational medical technology, biotechnology, pharmaceutical operations, and enterprise transformation.
His experience includes nearly five years based in Geneva, Switzerland, financial leadership and business partnering responsibilities at Takeda and Mass General Brigham, and consulting engagements with leading global pharmaceutical organizations.
Throughout his career, John has worked alongside senior executives, finance leaders, operating teams, investors, and cross-functional stakeholders, supporting strategic priorities, financial performance, investment planning, organizational transformation, and business growth.
His professional perspective has been shaped by experience in both established global enterprises and emerging businesses, where financial discipline, sound judgment, adaptability, and strong relationships are essential to advancing opportunities.
Today, through Zaya Advisory, John draws upon this background to work with executives, founders, investors, and organizations navigating strategic, financial, and operational decisions across industries, with particular depth in healthcare and life sciences.
His approach reflects a belief that lasting value is created not only through sound strategy and financial performance, but also through the people, relationships, and shared sense of purpose that turn possibilities into progress.
John’s Career Path
Brown Brothers Harriman, Boston · Dechert LLP, Philadelphia
John began his professional career at Brown Brothers Harriman in Boston, working within the firm’s Investor Services Client Service Group and supporting institutional asset servicing activities encompassing $100 billion in global investment funds, with particular emphasis on Europe, the Middle East, and Asia.
He subsequently joined Dechert LLP, an international law firm, supporting C-suite executives, the Global Policy Committee, managing partners, and the Chief Financial Officer through financial planning, profitability analysis, and strategic decision support.
These early experiences established a foundation in institutional finance, executive financial management, global business operations, and corporate strategy.
At Brown Brothers Harriman, John gained experience in institutional investment operations, global capital markets, asset servicing, and complex client relationships.
Working within a globally oriented financial institution provided exposure to sophisticated investment structures, cross-border financial activities, and the operational requirements of institutional investors.
The experience reinforced the importance of financial accuracy, disciplined execution, and trusted relationships in supporting large-scale international financial operations.
At Dechert, John supported executive leadership through financial planning, profitability assessment, business performance analysis, and strategic financial decision support.
His responsibilities included evaluating financial implications associated with the firm’s international expansion across Europe and Asia, its growing presence in New York, and its relocation to Philadelphia’s landmark Cira Centre.
Working in a sophisticated professional services environment strengthened his understanding of organizational economics, international growth, executive decision-making, and the relationship between financial strategy and enterprise performance.
Together, these experiences established the financial and strategic foundation for his subsequent international leadership roles.
Cardinal Health · Lloyds Private Banking | The Americas & Geneva, Switzerland
John joined Cardinal Health, initially supporting commercial finance and sales operations across Latin America and Canada for its respiratory and neurological medical device portfolio.
He subsequently advanced into international finance leadership and was selected for an expatriate assignment to Geneva, Switzerland, joining the extended international leadership team in a senior financial management role supporting Cardinal Health’s global medical technology businesses.
Following Cardinal Health, John joined Lloyds Private Banking in Geneva, serving on the Europe, Middle East, and Africa (EMEA) leadership team, with financial management responsibilities associated with $20 billion in assets under management.
Nearly five years living and working in Switzerland shaped his international outlook, understanding of diverse markets, and appreciation for cross-cultural leadership and business relationships.
At Cardinal Health, John began by supporting commercial finance and sales operations for respiratory and neurological medical technologies across Latin America and Canada.
His responsibilities subsequently expanded into international finance leadership, leading to his selection for an expatriate assignment in Geneva, Switzerland, a major center for international business and financial services.
As a member of Cardinal Health’s extended international leadership team, he held senior financial management responsibilities supporting global medical technology operations, including respiratory products marketed across approximately 90 countries.
His experience connected regional commercial finance, multinational business operations, international financial management, and the complexities of delivering medical technologies across diverse healthcare markets.
The progression from the Americas to Geneva represented an important chapter in his professional development, strengthening his international perspective and experience supporting global business leadership.
Following Cardinal Health, John joined Lloyds Private Banking in Geneva, serving on the Europe, Middle East, and Africa (EMEA) leadership team.
His responsibilities included financial management activities associated with $20 billion in assets under management.
The role provided further experience in international banking, executive financial management, financial planning, and the institutional environment serving high-net-worth and ultra-high-net-worth clients.
Working across international markets reinforced the importance of disciplined financial oversight, sound governance, discretion, and long-term client relationships.
Together, his experiences at Cardinal Health and Lloyds Private Banking broadened his professional perspective across global finance, multinational healthcare technology, international leadership, and complex business operations.
State Street Global Exchange · Parabase Genomics
Upon returning to Boston, John consulted with State Street during the establishment of Global Exchange in 2013, supporting the development of a business combining financial data, investment research, analytics, and technology solutions for institutional investors.
During the same period, he also supported Parabase Genomics, an emerging molecular diagnostics company operating from the University of Massachusetts Boston Venture Development Center.
Serving in an interim financial leadership capacity, John helped secure $2 million in funding to establish laboratory operations in Boston’s Seaport area.
These experiences brought together his background in institutional finance, emerging technologies, financial strategy, and the growing biotechnology and innovation economy.
At State Street, John participated in a consulting engagement associated with the establishment of Global Exchange, a business bringing together financial data, investment research, analytics, and technology-enabled solutions.
The engagement provided exposure to the intersection of institutional financial services, information technology, data-driven business models, and enterprise-level organizational development.
This experience further expanded his perspective on how established financial institutions develop capabilities and respond to changing market requirements.
At Parabase Genomics, John supported an emerging molecular diagnostics business operating within the University of Massachusetts Boston Venture Development Center.
In an interim financial leadership capacity, John contributed to financial planning, fundraising, and operational development, helping secure $2 million in funding to establish laboratory operations in Boston’s Seaport innovation district.
The experience provided firsthand exposure to the financial and operational challenges faced by early-stage biotechnology companies, including capital requirements, infrastructure investment, laboratory development, and business formation.
It also marked an important connection between John’s financial leadership experience and the emerging field of genomic medicine.
Takeda · Mass General Brigham
At Takeda’s U.S. headquarters in Kendall Square, Cambridge, John held financial planning, analysis, and business partnering responsibilities supporting U.S. Medical Affairs, clinical research, and clinical operations, including activities associated with clinical operations hubs in Chicago.
Beyond his core financial responsibilities, John served as President of IGNITE Massachusetts, advancing cross-functional innovation, professional engagement, and connections across Boston’s biotechnology, academic, and business communities.
In 2023, John joined Mass General Brigham as Director of Finance for Enterprise Pathology, contributing to the early implementation of a major clinical integration initiative across the hospital system.
These experiences deepened his understanding of pharmaceutical operations, academic medicine, healthcare delivery, clinical organizations, and the financial and operational challenges facing complex healthcare enterprises.
At Takeda, John supported financial planning, analysis, and strategic business partnering within U.S. Medical Affairs and related clinical functions.
His work involved collaboration with medical, clinical, financial, and operational stakeholders to support resource planning, financial performance, and organizational priorities.
As President of IGNITE Massachusetts, John also contributed to initiatives encouraging innovation, collaboration, and professional connections across the region’s life sciences ecosystem.
This combination of formal financial responsibilities and broader leadership engagement strengthened his appreciation for the relationships connecting industry, scientific innovation, academic institutions, and regional economic development.
In 2023, John joined Mass General Brigham as Director of Finance for Enterprise Pathology.
His responsibilities involved financial leadership and support for a major clinical integration initiative across the health system’s pathology enterprise.
The role provided direct exposure to the organizational and financial complexities of a large academic healthcare system, including clinical service delivery, enterprise integration, financial management, and coordination across institutional stakeholders.
The experience broadened his perspective beyond pharmaceutical and medical technology businesses to include the operational realities of healthcare delivery and academic medicine.
Organon · Ipsen · Merck
John’s subsequent consulting engagements supported major pharmaceutical organizations navigating technology transformation, organizational restructuring, investment planning, and enterprise priorities.
At Organon, a global pharmaceutical company with a focus on women’s health, he served as Enterprise Information Technology (EIT) Project Management Office (PMO) Lead, supporting enterprise portfolio coordination, governance, and organizational priorities.
At Ipsen, John supported a major U.S. legal entity restructuring initiative spanning 18 functional workstreams, with implications across the company’s global operations.
At Merck, he supported Enterprise Information Technology portfolio and investment planning across Corporate Affairs, Strategy, and Business Development, contributing to planning activities associated with a major enterprise-wide SAP transformation initiative.
Together, these engagements reinforced his expertise in strategic finance, enterprise transformation, cross-functional coordination, and complex multinational business environments.
At Organon, John served in a consulting capacity as EIT PMO Lead.
His responsibilities focused on enterprise technology portfolio coordination, project management governance, business priorities, and organizational alignment.
The engagement strengthened his experience working across business and technology functions within a global pharmaceutical environment.
At Ipsen, John supported a significant U.S. legal entity restructuring initiative involving 18 functional workstreams.
The engagement required coordination across stakeholders and business functions, with implications extending into the company’s global operations.
The experience further developed his understanding of the financial, operational, organizational, and governance considerations involved in complex corporate restructuring.
At Merck, John supported EIT portfolio and investment planning for Corporate Affairs, Strategy, and Business Development.
His work contributed to investment prioritization, financial planning, and portfolio management activities within the context of a major enterprise-wide SAP transformation initiative.
The engagement brought together strategic finance, enterprise technology investment, business transformation, and cross-functional stakeholder management at a leading global pharmaceutical organization.
Boston · Washington, D.C. · International Engagement
John has maintained a longstanding interest in emerging technologies, international healthcare, scientific innovation, and the developments shaping the future of medicine.
Following his diagnosis and treatment for prostate cancer in 2024, he began increasingly connecting his professional experience in healthcare and life sciences with a personal commitment to cancer patient advocacy.
His subsequent engagement with oncology researchers, healthcare leaders, patient advocates, scientific organizations, and international stakeholders has broadened his perspective on the challenges and opportunities facing patients, particularly adolescents and young adults (AYA) and adults diagnosed with cancer earlier in life.
In 2026, his activities included participation as a patient advocate at the American Society for Radiation Oncology (ASTRO) Annual Meeting, engagement with medical technology and life sciences communities in Boston, and attendance at the National Foundation for Cancer Research Global Summit and Awards in Washington, D.C.
These experiences have brought together his background in financial strategy, multinational healthcare, medical technology, biotechnology, pharmaceutical operations, and enterprise transformation with a personal understanding of cancer treatment, survivorship, and the patient experience.
They have also reinforced his belief in the importance of thoughtful collaboration among patients, researchers, clinicians, industry leaders, and organizations working to advance cancer research and care.
John’s expanding involvement in the oncology community has helped inform the establishment of Zaya’s Global Initiative (ZGI), an emerging nonprofit focused on advocacy, connection, and international collaboration for adolescents and young adults affected by cancer.
Explore Leadership & EngagementHow John Works
John believes effective advisory relationships begin with trust, thoughtful dialogue, and a clear understanding of the people and organizations involved.
His approach combines financial discipline, strategic perspective, practical experience, and an appreciation for the relationships that move ideas forward.
Open, thoughtful guidance grounded in experience, professional judgment, and integrity.
Bringing perspective to complex situations, identifying priorities, and connecting strategic objectives with financial and operational realities.
Building relationships grounded in trust, mutual respect, collaboration, and a long-term perspective.
Moving beyond analysis to actionable priorities, informed decisions, and measurable progress.
Education & Background
Academic Foundation
John earned a Bachelor of Science in Business Administration and Finance from Villanova University and a Master of Business Administration in International Business from Suffolk University in Boston.
His academic background established a foundation in finance, business strategy, international markets, and organizational leadership.
Executive Education & Continuing Development
John has continued his professional development through executive and graduate-level education, including an Executive Leadership Certificate from Cornell University, graduate study in administration and management and marketing social change at Harvard, and leadership communication programs associated with Dartmouth and the Stanford Graduate School of Business.
These experiences reflect an ongoing interest in leadership, business transformation, communication, and the evolving relationship between organizations and society.
Global Perspective
Nearly five years based in Geneva, Switzerland, together with professional experience involving Europe, the Middle East, Latin America, Canada, and Asia-Pacific, have shaped John’s international perspective.
His work across multinational businesses, financial institutions, healthcare organizations, and emerging enterprises has reinforced an appreciation for diverse markets, cultures, professional disciplines, and approaches to problem-solving.
That perspective continues to inform his approach to strategy, finance, relationship development, and international collaboration.
ESTRO & IPOS
These memberships reflect John’s engagement with the international oncology community across cancer research, treatment innovation, psychosocial care, and survivorship.
Both memberships are held by John individually. They are not organizational partnerships with, or endorsements by, either society.

Zaya’s Global Initiative (ZGI)
In 2024, John was diagnosed with Stage III prostate cancer at age 45.
Following surgery and treatment, his experience as a patient introduced a new dimension to a career already deeply connected to healthcare, life sciences, medical technology, and scientific innovation.
As he engaged more closely with the oncology community, John became particularly interested in the experiences of people diagnosed with cancer during adolescence and young adulthood, including those navigating treatment, relationships, family responsibilities, careers, financial uncertainty, and survivorship.
His experience also reinforced the importance of listening to patients, recognizing the broader impact of a cancer diagnosis, and strengthening connections among the communities working to advance research and care.
Drawing upon his international professional background and growing relationships across oncology, research, healthcare, and patient advocacy, John founded Zaya’s Global Initiative (ZGI) in 2026.

Zaya’s Global Initiative (ZGI) is an emerging nonprofit dedicated to supporting adolescents and young adults affected by cancer worldwide through advocacy, connection, and collaboration.
The initiative seeks to amplify patient perspectives, foster meaningful relationships, and encourage cooperation across geographic, institutional, and professional boundaries.
Rooted in personal experience and shaped by an international outlook, Zaya’s Global Initiative (ZGI) reflects John’s belief that meaningful progress often begins when people with different backgrounds, experiences, and capabilities come together around a shared purpose.
While Zaya Advisory and Zaya’s Global Initiative (ZGI) serve distinct missions, both reflect a consistent philosophy: connecting people, expanding possibilities, and working toward meaningful progress.
People. Partnerships. Possibility. Purpose.
Learn About Zaya’s Global Initiative (ZGI)Crafted by LocalForge